JNJ-64530440, a novel capsid assembly modulator: single- and multiple-ascending dose safety, tolerability and pharmacokinetics in healthy volunteers

被引：7

作者：

Kakuda, Thomas ^{[1
]}

Yogaratnam, Jeysen ^{[1
]}

Westland, Christopher ^{[1
]}

Gane, Edward ^{[2
]}

Schwabe, Christian ^{[3
]}

Patel, Megha ^{[1
]}

Talloen, Willem ^{[4
]}

Lenz, Oliver ^{[4
]}

van Remoortere, Pieter ^{[5
]}

机构：

[1] Janssen BioPharma Inc, San Francisco, CA USA

[2] Univ Auckland, New Zealand Liver Transplant Unit, Auckland, New Zealand

[3] Auckland Clin Studies, Auckland, New Zealand

[4] Janssen Pharmaceut NV, Beerse, Belgium

[5] Janssen Pharmaceut, Titusville, FL USA

来源：

关键词：

D O I：

10.1016/S0618-8278(19)30925-9

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI-180

引用

页码：E469 / E469

页数：1